𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Role of infliximab in ulcerative colitis: Further questions

✍ Scribed by Charles W. Lees; Alan G. Shand; Ian D. Penman; Jack Satsangi; Ian D.R. Arnott

Book ID
110087384
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
101 KB
Volume
12
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Infliximab efficacy in pediatric ulcerat
Infliximab efficacy in pediatric ulcerative colitis
✍ Alexandra P Eidelwein; Carmen Cuffari; Vivian Abadom; Maria Oliva-Hemker πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 114 KB
Predictors of early response to inflixim
Predictors of early response to infliximab in patients with ulcerative colitis
✍ Marc Ferrante; SΓ©verine Vermeire; Konstantinos H. Katsanos; Maja Noman; Gert Van πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 183 KB πŸ‘ 1 views

## Background: Our objective is to report the outcome of infliximab (ifx) in ulcerative colitis (uc) patients from a single center and to identify predictors of early clinical response. ## Methods: The first 100 uc patients (45 female; median age, 37.9 years) who received ifx at a single center w